EMPOWER

Stop & Shop Kicks Off Annual ‘Help Cure Childhood Cancer’ Campaign

Retrieved on: 
Friday, March 3, 2023

Stop & Shop’s ‘Help Cure Childhood Cancer’ campaign will run in all stores from March 3 through April 2.

Key Points: 
  • Stop & Shop’s ‘Help Cure Childhood Cancer’ campaign will run in all stores from March 3 through April 2.
  • 100% of proceeds will benefit the two hospitals to assist in their pioneering pediatric cancer treatment and care.
  • As pioneers in research, MSK’s physicians and scientists are working to develop and deliver more effective strategies to prevent, treat and cure childhood cancer.
  • The Stop & Shop Pediatric Brain Tumor Clinic at Dana-Farber Cancer Institute is a world-renowned destination for children with malignant and nonmalignant brain tumors.

Vicinity Energy Partners with Baltimore Gas and Electric on Key Infrastructure Investment in Baltimore

Retrieved on: 
Tuesday, February 28, 2023

Vicinity invested $2 million to upgrade their district chilled water plants with piping upgrades, variable frequency drives on large motors, improved instrumentation, and sophisticated computer optimization software.

Key Points: 
  • Vicinity invested $2 million to upgrade their district chilled water plants with piping upgrades, variable frequency drives on large motors, improved instrumentation, and sophisticated computer optimization software.
  • This project improved equipment and controls at the Vicinity chilled water system located in Baltimore.
  • Optimum Energy LLC provided the engineering and optimization software that is the heart of the efficiency project.
  • “By partnering with forward-thinking companies like Vicinity we are able to bring the State of Maryland closer to its decarbonization goals.

New Preeclampsia Research Funded to Investigate Genetic Targets to Develop Potential Therapeutics

Retrieved on: 
Wednesday, February 8, 2023

Based on the recommendations of its Scientific Advisory Council, the Preeclampsia Foundation awarded a grant totaling $99,994 USD to Wendy Kuohung, MD of Boston University.

Key Points: 
  • Based on the recommendations of its Scientific Advisory Council, the Preeclampsia Foundation awarded a grant totaling $99,994 USD to Wendy Kuohung, MD of Boston University.
  • The study is designed to potentially accelerate discovery of therapies for preeclampsia by designing placental cell lines that express variants of the APOL1 gene for drug screening.
  • "We lost our son Peter due to preeclampsia following a 29-week delivery in 2015," explained Lauren Pappas.
  • The Peter Joseph Pappas Research Grants program adds to the Preeclampsia Foundation's portfolio of research programs including the Vision Grant program for young investigators, PRIME for health services research, and EMPOWER, which helps build research capacity in low- and middle-income countries.

Cardiac Dimensions Raises $35 Million in Series D Financing

Retrieved on: 
Thursday, January 5, 2023

Cardiac Dimensions ®, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, today announced it has closed a $35 million Series D financing round.

Key Points: 
  • Cardiac Dimensions ®, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, today announced it has closed a $35 million Series D financing round.
  • Funds will also support expanded sales of the Carillon device in several European countries where it has full reimbursement.
  • This funding will enable us to continue providing Carillon therapy to a large population of patients in dire need of treatment,” said Cardiac Dimensions CEO Rick Wypych.
  • Previously published survival data on the Carillon device out to six years show favorable survival when compared to medical management.

Renewable Innovations (NBLD) Offers Mobile Power Generator (MPG) Systems and Will Use General Motors (GM) gen2 Hydrogen Fuel Cells

Retrieved on: 
Tuesday, December 6, 2022

Lindon, Utah, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Renewable Innovations (RI) (OTC: NBLD) has received purchase orders from Fortune 50 Companies for its MPG (Mobile Power Generator) and for other hydrogen-related projects. Hydrogen fuel cells could offer a fully renewable and clean power source for stationary and mobile applications in the near future.

Key Points: 
  • Hydrogen fuel cells could offer a fully renewable and clean power source for stationary and mobile applications in the near future.
  • General Motors will be supplying HYDROTEC Gen2 fuel cells and lithium-ion batteries to Renewable Innovations for installation in these first units.
  • “GM is supplying HYDROTEC fuel cell power cubes to Renewable Innovations of Lindon, Utah to build the Mobile Power Generator.
  • “Our expectation is to deliver multiple green-power systems to the market using hydrogen fuel cells,” Said Robert Mount, CEO of Renewable Innovations.

Shockwave Medical Publishes Inaugural ESG Report

Retrieved on: 
Wednesday, November 16, 2022

SANTA CLARA, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the publication of its inaugural Environmental, Social and Governance (ESG) report highlighting the companys corporate responsibility and sustainability initiatives.

Key Points: 
  • SANTA CLARA, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the publication of its inaugural Environmental, Social and Governance (ESG) report highlighting the companys corporate responsibility and sustainability initiatives.
  • Our entire global organization is committed to operating responsibly, sustainably, and transparently and I am impressed by how our teams across Shockwave have embraced the practices associated with ESG, said Doug Godshall, President and Chief Executive Officer of Shockwave Medical.
  • At the core of our values is helping people, and the efforts associated with ESG extend these values beyond Shockwave and IVL for calcified vessels and to the broader world around us.
  • Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated.

#WEDO2022 agenda, celebrated the pivotal role women play in the impact of disruptive technologies and the positive impact this community is having globally

Retrieved on: 
Thursday, November 24, 2022

NEW YORK, Nov. 23, 2022 /PRNewswire-PRWeb/ -- The Annual International Women's Entrepreneurship Day (WED) convened at the Delegates Dining Room at the United Nations in New York City on Saturday, November 19, 2022. November 19 was the official internationally proclaimed day. The summit was presented by the Women's Entrepreneurship Day Organization (WEDO), a non-governmental volunteer organization with a mission to economically empower women and to alleviate poverty worldwide.

Key Points: 
  • WEDO ignites a network of women leaders, innovators, and entrepreneurs to initiate startups, drive economic expansion, and advance communities around the world.
  • We are dedicated, determined and driven to change this global imbalance," states Wendy Diamond, Founder of the Women's Entrepreneurship Day Organization.
  • The positive impact of The Women's Entrepreneurship Day Organization (WEDO) around the world, with a focus on recent impact in the Ukraine.
  • Join Our Social Impact Campaign on November 30, 2022 and CELEBRATE, EMPOWER, AND SUPPORT WOMEN IN BUSINESS TO ALLEVIATE POVERTY.

Dubai Electricity and Water Authority PJSC 9M-2022 profit rises 21% to AED 6.47 billion

Retrieved on: 
Thursday, November 10, 2022

Dubai Electricity and Water Authority PJSC (ISIN: AED001801011) (Symbol: DEWA), the Emirate of Dubais exclusive electricity and water services provider, which is listed on the Dubai Financial Market (DFM), has reported its third quarter 2022 financial results, recording quarterly revenue of AED 8.55 bn and net profit of AED 3.17 bn.

Key Points: 
  • Dubai Electricity and Water Authority PJSC (ISIN: AED001801011) (Symbol: DEWA), the Emirate of Dubais exclusive electricity and water services provider, which is listed on the Dubai Financial Market (DFM), has reported its third quarter 2022 financial results, recording quarterly revenue of AED 8.55 bn and net profit of AED 3.17 bn.
  • Year to date, DEWAs revenue is AED 20.63 bn and net profit is AED 6.47 bn.
  • View the full release here: https://www.businesswire.com/news/home/20221110005703/en/
    Dubai Electricity and Water Authority PJSC 9M-2022 profit rises 21% to AED 6.47 billion (Graphic: AETOSWire)
    DEWAs first 9 month revenue increase of 15% to AED 20.63 bn was mainly driven by an increase in demand and a transition to normalized tariff structure.
  • Energy demand in Dubai during the first 9 months of 2022 increased by 5% compared to the same period in 2021.

Women's Entrepreneurship Day Organization (WEDO) #WEDO2022 Summit

Retrieved on: 
Friday, November 4, 2022

NEW YORK, Nov. 4, 2022 /PRNewswire-PRWeb/ -- Women's Entrepreneurship Day Organization (WEDO) #WEDO2022 Summit Delegates Dining Room United Nations New York City November 19, 2022 |10:00 am – 3:00 pm

Key Points: 
  • The summit is presented by the Women's Entrepreneurship Day Organization (WEDO), a non-governmental volunteer organization with a mission to economically empower women and alleviate poverty worldwide.
  • We are dedicated, determined and driven to change this global imbalance," states Wendy Diamond, Founder of the Women's Entrepreneurship Day Organization.
  • The positive impact of The Women's Entrepreneurship Day Organization (WEDO) around the world, with a focus on recent impact in Ukraine.
  • She was inspired to launch Women's Entrepreneurship Day Organization (WEDO)/#ChooseWOMEN in 2013 after volunteering in Honduras with the Adelante Foundation, an organization that provides microcredit to locally impoverished women.

Feinstein Institutes, Northwell electrophysiologist successfully implant first modular cardiac rhythm management system in novel clinical trial

Retrieved on: 
Friday, October 21, 2022

Like a paramedic in your chest, a team of Northwell Health clinicians, electrophysiologists and clinical trial investigators at The Feinstein Institutes for Medical Research successfully implanted a modular cardiac rhythm management (CRM) system in the first patient to be enrolled in the Boston Scientific MODULAR ATP clinical trial.

Key Points: 
  • Like a paramedic in your chest, a team of Northwell Health clinicians, electrophysiologists and clinical trial investigators at The Feinstein Institutes for Medical Research successfully implanted a modular cardiac rhythm management (CRM) system in the first patient to be enrolled in the Boston Scientific MODULAR ATP clinical trial.
  • View the full release here: https://www.businesswire.com/news/home/20221021005348/en/
    Laurence M. Epstein, MD (center right) implanted the first patient in Boston Scientifics MODULAR ATP clinical trial at North Shore University Hospital.
  • The trial will also investigate the system and procedure-related complication-free rate of the EMPOWER MPS.
  • The MODULAR ATP trial will enroll up to 60 centers in the U.S., Canada and Europe up to 300 patients.